Thomas Uldrick, MD

Physician I Scientist l Immuno-oncology Drug Development I Virus Associated Cancers I Global Health Equity l tweets are my own. 🏳️‍🌈

[Anne Applebaum @anneapplebaum]

Please share this fact sheet about Ukraine with anyone who needs it

[The Lincoln Project @ProjectLincoln]

THREAD: Trump's intentionally flooding the zone w/ a stream of outrage porn like calling himself "king" to distract you. Here's the stories that actually matter that you might've missed this week:

NIH funding cuts jeopardize ‘life-saving’ research in AL
https://t.co/nn21zSeFvg

[Sasha Gusev @SashaGusevPosts]

I wrote up an FAQ about the recent federal grant cuts. A few key points 🧵:

[Thomas Uldrick, MD @ThomasUldrick]

"Keeping the CDC and EIS personnel fully staffed can actually reduce costs in the long-run by early detection and prevention of many potential public health threats."

[Omer Awan MD MPH @AwanRad]

My latest in @Forbes - Trump Administration lays off critical @CDCgov workers, threatening public health. https://t.co/DQvvgH2DXu. @DrIanWeissman @nkagetsu @CaulfieldTim @doritmi @jonathanstea @DrLindaMD @alihusnain186 @paimadhu

[Farzad Mostashari @Farzad_MD]

1/ After residency at Mass General Hospital, I reported to Atlanta to meet my fellow CDC Epidemic Intelligence Service Officers.

I have never felt so intimidated by my peers

The best and the brightest, they were star clinicians, had served in disaster zones; MD/PhDs and MSF.

[Journal for ImmunoTherapy of Cancer @jitcancer]

New #JITC article: Phase I study of efineptakin alfa (NT-I7) for the treatment of Kaposi sarcoma https://t.co/f0bh2nJ9nn @DrKateLurain @Fluffone @ThomasUldrick @theNCI @fredhutch

[Sen. Lisa Murkowski @lisamurkowski]

Efficiency in government should be a goal for every administration, agency, and federal employee. But how we achieve it also matters. By circumventing proper channels and procedures, and creating the potential to compromise the sensitive data of Americans, we create a tremendous amount of unnecessary anxiety. That is wrong. Good governance is based on trust, not fear.

[AmericanJournalofHematology @AjHematology]

PEL-PS is a new validated prognostic score predicting OS in #HIV+ Primary Effusion #Lymphoma using ECOG and hemoglobin

Good PEL-PS (Hb ≥8 g/dL and ECOG ≤2) had median OS >10 years
https://t.co/bZDkeOvyjK

[Thomas Uldrick, MD @ThomasUldrick]

Congrats to the C-POST team on the positive interim results from this well designed and rigorously conducted study!

[Regeneron @Regeneron]

We are excited to share the first-ever positive interim data for adjuvant immunotherapy in high-risk #CSCC, a form of non-melanoma #skincancer. Read more about the Phase 3 trial results in this investigational indication.

[Gavin Newsom @GavinNewsom]

A lot of misinformation out there.

Just launched a new site to ensure the public has access to fact-based data around the Southern CA wildfires.

The TRUTH:
- CA did NOT cut our firefighting budget. We have nearly doubled the size of our firefighting army and built the world’s largest aerial firefighting fleet.
- CA has INCREASED forest management ten-fold since we took office.
- California will NOT allow for looting.

Get the facts: https://t.co/kgUOGhcC0D

[Thomas Uldrick, MD @ThomasUldrick]

wow!

[Stephen Gibbs @STHGibbs]

The Venezuelan conductor Gustavo Dudamel directing the South African soprano Pretty Yende and the Orchestre Philharmonique de Radio France, in this pitch-perfect rendition of Amazing Grace at Notre Dame today.

[WashU Medicine Division of Oncology @WashUOncology]

New research from @ThomasOdeny and team highlights the promise of immunotherapy for HIV-associated Kaposi sarcoma in treating KS in people living with HIV. #CancerResearch #HIV #Immunotherapy #KaposiSarcoma
Read More: https://t.co/mH5szdbuaT

[Thomas Uldrick, MD @ThomasUldrick]

@wagsmd @JCO_ASCO @DrKateLurain @EladSharonMD Thanks for contributing to this study!!!

[Thomas Uldrick, MD @ThomasUldrick]

@EladSharonMD @AaronGoodman33 @NCItreatment @NCIResearchCtr @fredhutch @theNCI @JCO_ASCO @Dr_R_Kurzrock There was equipoise about anti-pd1 in HIV-KS. NCCN only supports in classic KS. Our 29 person prospective study has similar est of benefit to the 9 patent retrospective experience. Growing evidence will hopefully increase impact of findings for HIV KS patients, which matters!

[Thomas Uldrick, MD @ThomasUldrick]

Hot off the press from @DrKateLurain @ramya_ramaswami @ThomasOdeny @EladSharonMD @DiseaseDR Important new data showing high and durable activity for anti-PD1 in HIV-KS!
CITN12: Pembro in HIV-Associated Kaposi Sarcoma | JCO https://t.co/X9AtRySMUv

[Harvard Radiation Oncology Program @HarvardRadOnc]

We are full of grief with the loss of a dear friend and a beautiful, courageous person, wife, mother, physician, and advocate for improving care for all, Dr. Shekinah Elmore (HROP class of 2020).

[Thomas Uldrick, MD @ThomasUldrick]

Congrats to the amazing Dr Dr. D!

[Dr. H. Ddungu @ddunguh]

#PhD in my hands ⁦@Makerere⁩ ⁦@MakerereCHS⁩ ⁦@MakCHS_SOM⁩ ⁦@LeMemorialUg⁩

[Thomas Uldrick, MD @ThomasUldrick]

@DJPinato @imperialcollege @UniAvogadro @ALEDIGNUS12 @A_DAlessioMD @profbower @MarkYarchoan @MdCurioni @FulgenziClaudia @CiroCelsa @ACortelliniMD congrats! Well deserved.

[Thomas Uldrick, MD @ThomasUldrick]

Wish I were @ASH to see @DrKateLurain et al's important https://t.co/gJjhi4nH0F on CATCH-IT RWE for anti-PD1 in #HIV #Hodgkin #lymphoma today. Encouraging activity after med 2nd line Tx in EBV+ disease (unique biology in HIV ): 70% CR rate, 20 mo DOR including in low CD4!

[Thomas Uldrick, MD @ThomasUldrick]

Congrats @keithsigelmd !

[Mount Sinai Tisch Cancer Center @TischCancer]

Mount Sinai Awarded $3.4 Million to Study Prostate Cancer in People With HIV https://t.co/mxU9D6LM3c via @onclive
#ProstateCancer @IcahnMountSinai @keithsigelmd